Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Genesis (New York, N.Y. : 2000)
|
June 18, 2026
Multiplexed Retinoic Acid Signal Reporters for In Vivo and In Vitro Use
Craig Smith, Bianca Black, Ric Broadhurst, et al.
Journal of Extracellular Biology
|
June 28, 2024
Adipose derived stem cell extracellular vesicles modulate primary human macrophages to an anti-inflammatory phenotype in vitro
Emma K C Symonds, Bianca Black, Alexander Brown, et al.
BMC Complementary Medicine and Therapies
|
February 3, 2026
Randomised controlled trial of mānuka oil-based ECMT-154™ vs. vehicle control for the topical treatment of eczema, conducted in community pharmacies in New Zealand
Gabrielle Shortt, Georgina Bird, Nicholas Shortt, et al.
ERJ Open Research
|
July 9, 2025
Protocol for the INFORM ASTHMA Trial: budesonide-formoterol reliever in adults with asthma on maintenance inhaled corticosteroid
Jonathan Noble, Orlagh Bean, Pepa Bruce, et al.
Eclinicalmedicine
|
July 22, 2022
Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial
Nicholas Shortt, Alexander Martin, Kyley Kerse, et al.
BMC Complementary Medicine and Therapies
|
January 29, 2024
Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand
Gabrielle Shortt, Nicholas Shortt, Georgina Bird, et al.
The Lancet. Respiratory Medicine
|
January 11, 2026
Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial
Jonathan H Noble, Orlagh Bean, Melissa Perry, et al.
ERJ Open Research
|
April 9, 2024
START CARE: a protocol for a randomised controlled trial of step-wise budesonide-formoterol reliever-based treatment in children
Tasmin Barry, Mark Holliday, Jenny Sparks, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Genesis (New York, N.Y. : 2000)
|
June 18, 2026
Multiplexed Retinoic Acid Signal Reporters for In Vivo and In Vitro Use
Craig Smith, Bianca Black, Ric Broadhurst, et al.
Journal of Extracellular Biology
|
June 28, 2024
Adipose derived stem cell extracellular vesicles modulate primary human macrophages to an anti-inflammatory phenotype in vitro
Emma K C Symonds, Bianca Black, Alexander Brown, et al.
BMC Complementary Medicine and Therapies
|
February 3, 2026
Randomised controlled trial of mānuka oil-based ECMT-154™ vs. vehicle control for the topical treatment of eczema, conducted in community pharmacies in New Zealand
Gabrielle Shortt, Georgina Bird, Nicholas Shortt, et al.
ERJ Open Research
|
July 9, 2025
Protocol for the INFORM ASTHMA Trial: budesonide-formoterol reliever in adults with asthma on maintenance inhaled corticosteroid
Jonathan Noble, Orlagh Bean, Pepa Bruce, et al.
Eclinicalmedicine
|
July 22, 2022
Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial
Nicholas Shortt, Alexander Martin, Kyley Kerse, et al.
BMC Complementary Medicine and Therapies
|
January 29, 2024
Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand
Gabrielle Shortt, Nicholas Shortt, Georgina Bird, et al.
The Lancet. Respiratory Medicine
|
January 11, 2026
Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial
Jonathan H Noble, Orlagh Bean, Melissa Perry, et al.
ERJ Open Research
|
April 9, 2024
START CARE: a protocol for a randomised controlled trial of step-wise budesonide-formoterol reliever-based treatment in children
Tasmin Barry, Mark Holliday, Jenny Sparks, et al.
Page
of 1